Katrina Yates

631 total citations
8 papers, 498 citations indexed

About

Katrina Yates is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Katrina Yates has authored 8 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Medicine, 6 papers in Pharmacology and 6 papers in Epidemiology. Recurrent topics in Katrina Yates's work include Antibiotic Resistance in Bacteria (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Urinary Tract Infections Management (3 papers). Katrina Yates is often cited by papers focused on Antibiotic Resistance in Bacteria (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Urinary Tract Infections Management (3 papers). Katrina Yates collaborates with scholars based in United Kingdom, United States and Czechia. Katrina Yates's co-authors include Paul Newell, Gregory G. Stone, Leanne B. Gasink, J. Armstrong, Jack D. Sobel, Florian Wagenlehner, Xiangning Huang, Helen Broadhurst, Angela Wardman and Karen Cheng and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Katrina Yates

8 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katrina Yates United Kingdom	7	408	342	240	173	41	8	498
Obiamiwe Umeh United States	6	462 1.1×	405 1.2×	297 1.2×	190 1.1×	64 1.6×	9	606
Angela Wardman United Kingdom	5	398 1.0×	296 0.9×	181 0.8×	170 1.0×	44 1.1×	6	455
Jennifer A. Huntington United States	15	673 1.6×	578 1.7×	412 1.7×	294 1.7×	51 1.2×	26	847
Kate Sulham United States	10	252 0.6×	121 0.4×	257 1.1×	161 0.9×	124 3.0×	19	487
Christopher Bruno United States	12	357 0.9×	302 0.9×	252 1.1×	192 1.1×	30 0.7×	37	527
Jennifer Sekeres United States	5	244 0.6×	98 0.3×	194 0.8×	69 0.4×	92 2.2×	7	379
Cláudia Murta de Oliveira United States	6	236 0.6×	172 0.5×	143 0.6×	125 0.7×	38 0.9×	6	372
Juan Alcalá Spain	5	274 0.7×	63 0.2×	230 1.0×	80 0.5×	47 1.1×	5	374
Yuag-Meng Liu Taiwan	8	193 0.5×	68 0.2×	131 0.5×	89 0.5×	50 1.2×	8	358
Islam M. Ghazi United States	10	197 0.5×	129 0.4×	96 0.4×	101 0.6×	28 0.7×	35	320

Countries citing papers authored by Katrina Yates

Since Specialization

Citations

This map shows the geographic impact of Katrina Yates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrina Yates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrina Yates more than expected).

Fields of papers citing papers by Katrina Yates

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrina Yates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrina Yates. The network helps show where Katrina Yates may publish in the future.

Co-authorship network of co-authors of Katrina Yates

This figure shows the co-authorship network connecting the top 25 collaborators of Katrina Yates. A scholar is included among the top collaborators of Katrina Yates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrina Yates. Katrina Yates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Cheng, Karen, Paul Newell, Joseph W. Chow, et al.. (2020). Safety Profile of Ceftazidime–Avibactam: Pooled Data from the Adult Phase II and Phase III Clinical Trial Programme. Drug Safety. 43(8). 751–766. 18 indexed citations

Bradley, John S., Helen Broadhurst, Karen Cheng, et al.. (2019). Safety and Efficacy of Ceftazidime-Avibactam Plus Metronidazole in the Treatment of Children ≥3 Months to <18 Years With Complicated Intra-Abdominal Infection: Results From a Phase 2, Randomized, Controlled Trial. The Pediatric Infectious Disease Journal. 38(8). 816–824. 49 indexed citations

Bradley, John S., Emmanuel Roilides, Helen Broadhurst, et al.. (2019). Safety and Efficacy of Ceftazidime–Avibactam in the Treatment of Children ≥3 Months to <18 Years With Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Controlled Trial. The Pediatric Infectious Disease Journal. 38(9). 920–928. 56 indexed citations

Nichols, Wright W., Gregory G. Stone, Paul Newell, et al.. (2018). Ceftazidime-Avibactam Susceptibility Breakpoints against Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 62(11). 28 indexed citations

Stone, Gregory G., Paul Newell, Leanne B. Gasink, et al.. (2018). Clinical activity of ceftazidime/avibactam against MDR Enterobacteriaceae and Pseudomonas aeruginosa: pooled data from the ceftazidime/avibactam Phase III clinical trial programme. Journal of Antimicrobial Chemotherapy. 73(9). 2519–2523. 65 indexed citations

Wagenlehner, Flo ri an, Jack D. Sobel, Paul Newell, et al.. (2016). Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program. Clinical Infectious Diseases. 63(6). 754–762. 259 indexed citations

Stone, Gregory G., Leanne B. Gasink, Paul Newell, et al.. (2016). Efficacy of Ceftazidime-Avibactam against Multi-Drug Resistant Enterobacteriaceae and Pseudomonas aeruginosa from the Phase 3 Clinical Trial Program. Open Forum Infectious Diseases. 3(suppl_1). 1 indexed citations

Stone, Gregory G., Patricia A. Bradford, Katrina Yates, & Paul Newell. (2016). In vitroactivity of ceftazidime/avibactam against urinary isolates from patients in a Phase 3 clinical trial programme for the treatment of complicated urinary tract infections. Journal of Antimicrobial Chemotherapy. 72(5). dkw561–dkw561. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact